Literature DB >> 21718709

Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.

Jinshui Fan1, Carine Robert, Yoon-Young Jang, Hua Liu, Saul Sharkis, Stephen Bruce Baylin, Feyruz Virgilia Rassool.   

Abstract

To maintain the integrity of the organism, embryonic stem cells (ESC) need to maintain their genomic integrity in response to DNA damage. DNA double strand breaks (DSBs) are one of the most lethal forms of DNA damage and can have disastrous consequences if not repaired correctly, leading to cell death, genomic instability and cancer. How human ESC (hESC) maintain genomic integrity in response to agents that cause DSBs is relatively unclear. Adult somatic cells can be induced to "dedifferentiate" into induced pluripotent stem cells (iPSC) and reprogram into cells of all three germ layers. Whether iPSC have reprogrammed the DNA damage response is a critical question in regenerative medicine. Here, we show that hESC demonstrate high levels of endogenous reactive oxygen species (ROS) which can contribute to DNA damage and may arise from high levels of metabolic activity. To potentially counter genomic instability caused by DNA damage, we find that hESC employ two strategies: First, these cells have enhanced levels of DNA repair proteins, including those involved in repair of DSBs, and they demonstrate elevated nonhomologous end-joining (NHEJ) activity and repair efficacy, one of the main pathways for repairing DSBs. Second, they are hypersensitive to DNA damaging agents, as evidenced by a high level of apoptosis upon irradiation. Importantly, iPSC, unlike the parent cells they are derived from, mimic hESC in their ROS levels, cell cycle profiles, repair protein expression and NHEJ repair efficacy, indicating reprogramming of the DNA repair pathways. Human iPSC however show a partial apoptotic response to irradiation, compared to hESC. We suggest that DNA damage responses may constitute important markers for the efficacy of iPSC reprogramming. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21718709      PMCID: PMC3872739          DOI: 10.1016/j.mrfmmm.2011.05.018

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  48 in total

Review 1.  The mechanism of human nonhomologous DNA end joining.

Authors:  Michael R Lieber
Journal:  J Biol Chem       Date:  2007-11-12       Impact factor: 5.157

2.  Linking double-stranded DNA breaks to the recombination activating gene complex directs repair to the nonhomologous end-joining pathway.

Authors:  Xiaoping Cui; Katheryn Meek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-15       Impact factor: 11.205

Review 3.  DNA repair in murine embryonic stem cells and differentiated cells.

Authors:  Elisia D Tichy; Peter J Stambrook
Journal:  Exp Cell Res       Date:  2008-02-26       Impact factor: 3.905

4.  In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins.

Authors:  Hua Liu; Yonghak Kim; Saul Sharkis; Luigi Marchionni; Yoon-Young Jang
Journal:  Sci Transl Med       Date:  2011-05-11       Impact factor: 17.956

5.  Human embryonic stem cells have enhanced repair of multiple forms of DNA damage.

Authors:  Scott Maynard; Anna Maria Swistowska; Jae Wan Lee; Ying Liu; Su-Ting Liu; Alexandre Bettencourt Da Cruz; Mahendra Rao; Nadja C de Souza-Pinto; Xianmin Zeng; Vilhelm A Bohr
Journal:  Stem Cells       Date:  2008-06-19       Impact factor: 6.277

6.  ATM mediates repression of DNA end-degradation in an ATP-dependent manner.

Authors:  Elias A Rahal; Leigh A Henricksen; Yuling Li; John J Turchi; Katherine S Pawelczak; Kathleen Dixon
Journal:  DNA Repair (Amst)       Date:  2008-01-22

7.  A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche.

Authors:  Yoon-Young Jang; Saul J Sharkis
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

Review 8.  Targeting base excision repair for chemosensitization.

Authors:  Sanjay Adhikari; Sujata Choudhury; Partha S Mitra; Jerita J Dubash; Shyama P Sajankila; Rabindra Roy
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

9.  Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.

Authors:  Annahita Sallmyr; Alan E Tomkinson; Feyruz V Rassool
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

Review 10.  Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.

Authors:  Annahita Sallmyr; Jinshui Fan; Feyruz Virgilia Rassool
Journal:  Cancer Lett       Date:  2008-05-07       Impact factor: 8.679

View more
  30 in total

Review 1.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

Review 2.  Targeted gene therapies: tools, applications, optimization.

Authors:  Olivier Humbert; Luther Davis; Nancy Maizels
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 May-Jun       Impact factor: 8.250

Review 3.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

4.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Authors:  Aaron R Quinlan; Michael J Boland; Mitchell L Leibowitz; Svetlana Shumilina; Sidney M Pehrson; Kristin K Baldwin; Ira M Hall
Journal:  Cell Stem Cell       Date:  2011-10-04       Impact factor: 24.633

5.  Human pluripotent stem cells have a novel mismatch repair-dependent damage response.

Authors:  Bo Lin; Dipika Gupta; Christopher D Heinen
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

Review 6.  DNA triplet repeat expansion and mismatch repair.

Authors:  Ravi R Iyer; Anna Pluciennik; Marek Napierala; Robert D Wells
Journal:  Annu Rev Biochem       Date:  2015-01-02       Impact factor: 23.643

7.  Dynamic Variations in Genetic Integrity Accompany Changes in Cell Fate.

Authors:  I-Chung Chen; Christine Hernandez; Xueping Xu; Austin Cooney; Yufeng Wang; John R McCarrey
Journal:  Stem Cells Dev       Date:  2016-10-12       Impact factor: 3.272

8.  DNA damage response in neonatal and adult stromal cells compared with induced pluripotent stem cells.

Authors:  Stefanie Liedtke; Sophie Biebernick; Teja Falk Radke; Daniela Stapelkamp; Carolin Coenen; Holm Zaehres; Gerhard Fritz; Gesine Kogler
Journal:  Stem Cells Transl Med       Date:  2015-04-21       Impact factor: 6.940

Review 9.  Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.

Authors:  Ajay Srinivasan; Barry Gold
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

10.  ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.

Authors:  Vivek Shukla; Mahadev Rao; Hongen Zhang; Jeanette Beers; Darawalee Wangsa; Danny Wangsa; Floryne O Buishand; Yonghong Wang; Zhiya Yu; Holly S Stevenson; Emily S Reardon; Kaitlin C McLoughlin; Andrew S Kaufman; Eden C Payabyab; Julie A Hong; Mary Zhang; Sean Davis; Daniel Edelman; Guokai Chen; Markku M Miettinen; Nicholas P Restifo; Thomas Ried; Paul A Meltzer; David S Schrump
Journal:  Cancer Res       Date:  2017-09-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.